Dóra Balogh

457 total citations
22 papers, 344 citations indexed

About

Dóra Balogh is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Dóra Balogh has authored 22 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Dóra Balogh's work include Pharmacological Receptor Mechanisms and Effects (6 papers), Diabetes Treatment and Management (5 papers) and Receptor Mechanisms and Signaling (5 papers). Dóra Balogh is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (6 papers), Diabetes Treatment and Management (5 papers) and Receptor Mechanisms and Signaling (5 papers). Dóra Balogh collaborates with scholars based in Hungary, Denmark and Austria. Dóra Balogh's co-authors include Andrea Fekete, László Wagner, Attila J. Szabó, Judit Hodrea, Lilla Lénárt, Ádám Hosszú, Ádám Vannay, Federica Genovese, Nóra Fanni Bánki and Zsuzsanna Antal and has published in prestigious journals such as PLoS ONE, The Journal of Physiology and Diabetes.

In The Last Decade

Dóra Balogh

18 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dóra Balogh Hungary 10 158 119 77 60 40 22 344
Péter Degrell Hungary 13 156 1.0× 87 0.7× 62 0.8× 112 1.9× 69 1.7× 26 392
Yejun Zhao United States 9 122 0.8× 50 0.4× 64 0.8× 31 0.5× 52 1.3× 13 371
Monique G. de Sain-van der Velden Netherlands 8 64 0.4× 59 0.5× 97 1.3× 68 1.1× 29 0.7× 11 258
Jie Fang China 8 213 1.3× 108 0.9× 95 1.2× 17 0.3× 22 0.6× 25 427
Hideaki Nakaya Japan 12 153 1.0× 98 0.8× 22 0.3× 40 0.7× 20 0.5× 18 440
W. I. Bry United States 7 152 1.0× 56 0.5× 153 2.0× 25 0.4× 30 0.8× 15 447
Chunyuan Fan Japan 8 123 0.8× 48 0.4× 33 0.4× 21 0.3× 14 0.3× 12 368
Ting Fang China 9 121 0.8× 55 0.5× 51 0.7× 19 0.3× 6 0.1× 18 272
Maximilian Kopp Germany 7 156 1.0× 226 1.9× 129 1.7× 17 0.3× 42 1.1× 8 420
Nicolas Godin Canada 7 185 1.2× 74 0.6× 39 0.5× 122 2.0× 6 0.1× 8 437

Countries citing papers authored by Dóra Balogh

Since Specialization
Citations

This map shows the geographic impact of Dóra Balogh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dóra Balogh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dóra Balogh more than expected).

Fields of papers citing papers by Dóra Balogh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dóra Balogh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dóra Balogh. The network helps show where Dóra Balogh may publish in the future.

Co-authorship network of co-authors of Dóra Balogh

This figure shows the co-authorship network connecting the top 25 collaborators of Dóra Balogh. A scholar is included among the top collaborators of Dóra Balogh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dóra Balogh. Dóra Balogh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brubel, Réka, Beáta Polgár, László Szereday, et al.. (2025). Alteration of Serum Gal-3 Levels in Endometrium-Related Reproductive Disorders. International Journal of Molecular Sciences. 26(4). 1630–1630.
2.
Balogh, Dóra, et al.. (2024). Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. International Journal of Molecular Sciences. 25(24). 13327–13327. 1 indexed citations
3.
Balogh, Dóra, Gernot Hudelist, Christian M. Becker, et al.. (2024). FEMaLe: The use of machine learning for early diagnosis of endometriosis based on patient self-reported data—Study protocol of a multicenter trial. PLoS ONE. 19(5). e0300186–e0300186. 7 indexed citations
4.
Balogh, Dóra, et al.. (2023). Cardioprotective and Antifibrotic Effects of Low-Dose Renin–Angiotensin–Aldosterone System Inhibitors in Type 1 Diabetic Rat Model. International Journal of Molecular Sciences. 24(23). 17043–17043. 7 indexed citations
5.
Balogh, Dóra, László Wagner, & Andrea Fekete. (2023). An Overview of the Cardioprotective Effects of Novel Antidiabetic Classes: Focus on Inflammation, Oxidative Stress, and Fibrosis. International Journal of Molecular Sciences. 24(9). 7789–7789. 20 indexed citations
6.
Balogh, Dóra, Lilla Lénárt, Ádám Hosszú, et al.. (2023). 10-LB: Activation of Sigma-1 Receptor as a Novel Therapeutic Target in Diabetic Kidney Disease. Diabetes. 72(Supplement_1). 1 indexed citations
7.
Hodrea, Judit, Attila Fintha, László Wagner, et al.. (2022). SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes. PLoS ONE. 17(2). e0263285–e0263285. 28 indexed citations
8.
Balogh, Dóra, Judit Hodrea, Ádám Hosszú, et al.. (2021). MO620ANTIFIBROTIC EFFECTS OF SGLT2 INHIBITION IN THE KIDNEY AND PROXIMAL TUBULAR CELLS*. Nephrology Dialysis Transplantation. 36(Supplement_1). 1 indexed citations
9.
Hodrea, Judit, Dóra Balogh, Ádám Hosszú, et al.. (2020). Reduced O-GlcNAcylation and tubular hypoxia contribute to the antifibrotic effect of SGLT2 inhibitor dapagliflozin in the diabetic kidney. American Journal of Physiology-Renal Physiology. 318(4). F1017–F1029. 40 indexed citations
10.
Hosszú, Ádám, Dóra Balogh, Lilla Lénárt, et al.. (2020). Sigma‐1 Receptor Agonists Are Renoprotective in Experimental Kidney Transplantation. The FASEB Journal. 34(S1). 1–1.
11.
Balogh, Dóra, Ádám Hosszú, Judit Hodrea, et al.. (2020). Antidepressant effect in diabetes-associated depression: A novel potential of RAAS inhibition. Psychoneuroendocrinology. 118. 104705–104705. 15 indexed citations
12.
Lénárt, Lilla, Dóra Balogh, Nikolett Lénárt, et al.. (2019). Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling. Diabetologia. 62(8). 1501–1513. 19 indexed citations
13.
Lénárt, Lilla, Judit Hodrea, Dóra Balogh, et al.. (2018). RAAS inhibitors directly reduce diabetes‐induced renal fibrosis via growth factor inhibition. The Journal of Physiology. 597(1). 193–209. 73 indexed citations
14.
Hosszú, Ádám, Zsuzsanna Antal, Lilla Lénárt, et al.. (2018). The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia/reperfusion injury. Transplant International. 31(11). 1268–1278. 17 indexed citations
15.
Lénárt, Lilla, Judit Hodrea, Dóra Balogh, et al.. (2018). FP429THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AMELIORATE HYPERGLYCAEMIA INDUCED TUBULOINTERSITIAL FIBROSIS IN DIABETIC NEPHROPATHY. Nephrology Dialysis Transplantation. 33(suppl_1). i179–i179. 5 indexed citations
16.
Lénárt, Lilla, Judit Hodrea, Ádám Hosszú, et al.. (2016). The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats. Psychopharmacology. 233(7). 1269–1278. 21 indexed citations
17.
Hodrea, Judit, Lilla Lénárt, Ádám Hosszú, et al.. (2016). Role ofO-linkedN-acetylglucosamine modification in diabetic nephropathy. American Journal of Physiology-Renal Physiology. 311(6). F1172–F1181. 38 indexed citations
18.
19.
Balogh, Dóra, et al.. (1981). [Serum lactates in the reconstruction of the aortic bifurcation].. PubMed. 8(2). 96–100. 1 indexed citations
20.
Balogh, Dóra, et al.. (1978). [Postoperative fructose infusion in a case of presumed hereditary fructose intolerance (author's transl)].. PubMed. 90(7). 237–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Péter Degrell Breakdown of academic impact, for papers by Yejun Zhao Breakdown of academic impact, for papers by Monique G. de Sain-van der Velden Breakdown of academic impact, for papers by Jie Fang Breakdown of academic impact, for papers by Hideaki Nakaya Breakdown of academic impact, for papers by W. I. Bry Breakdown of academic impact, for papers by Chunyuan Fan Breakdown of academic impact, for papers by Ting Fang Breakdown of academic impact, for papers by Maximilian Kopp Breakdown of academic impact, for papers by Nicolas Godin
Rankless by CCL
2026